Assessment of sesame oil, sesame oil enriched with vitamin E and sunflower oil consumption effect on the lipid profile, glycemia, malondialdehyde and blood pressure in adults with metabolic syndrome

Comparison of sesame oil, sesame oil enriched with vitamin E and sunflower oil consumption effect on the lipid profile, glycemia, Malondialdehyde and blood pressure in adults with metabolic syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017042233582N1

Enrollment

Registered

2017-07-04

Start date

2016-12-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome. Metabolic disorder, unspecified

Interventions

Intervention 1: Intervention group 1: Daily intake of 30 grams of sesame oil enriched with vitamin E along with salad or diet for 8 weeks. Intervention 2: Intervention group 2 : Daily consumption of

Intervention group 1: Daily intake of 30 grams of sesame oil enriched with vitamin E along with salad or diet for 8 weeks

Intervention group 2 : Daily consumption of 30 grams of sesame oil along with salad or diet for 8 weeks

Control group : Daily consumption of 30 grams of Sunflower oil along with salad or diet for 8 weeks

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Waist circumference men = 102cm or 40in and women = 88cm or 35in, Fasting blood glucose = 100 mg per dl, HDL cholesterol for men < 40 mg per dl and for women < 50 mg per dl, Triglycerides = 150 mg per dl, Blood pressure = 130 and 85 mm Hg. Exclusion criteria: Chronic diseases such as thyroid disease, liver abnormalities and kidney disorders, Allergies to sunflower oil, sesame oil and tocopherol, Consumption of other drug such as Steroids or any NSAID, Simultaneous subscription in other interventional study, Pregnancy and lactating.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;High density lipoprotein-cholesterol. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Serum insulin. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Triglyceride. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Total cholesterol. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Low density lipoprotein-cholesterol. Timepoint: Beginning and end of the study. Method of measurement: Blood test.	—

Measure

Time frame

Fasting blood glucose. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;High density lipoprotein-cholesterol. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Serum insulin. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Triglyceride. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Total cholesterol. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Low density lipoprotein-cholesterol. Timepoint: Beginning and end of the study. Method of measurement: Blood test.

—

Secondary

Measure	Time frame
Waist circumference. Timepoint: Beginning and end of the study. Method of measurement: Tape measure.;Malondialdehyde. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Blood Pressure (systolic and diastolic). Timepoint: Beginning and end of the study. Method of measurement: Digital blood pressure monitor.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Farajbakhsh

Shiraz University of Medical Sciences

alifarajbakhsh@gmail.com00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026